COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases (COLDFIRE-III)
COLDFIRE-III Trial: Perivascular and Peribiliary Colorectal Liver Metastases (0-5cm): Irreversible Electroporation Versus Stereotactic Body Radiotherapy
Sponsor: Amsterdam UMC, location VUmc
This PHASE2/PHASE3 trial investigates Colorectal Cancer and Liver Metastases and is currently actively recruiting participants. Amsterdam UMC, location VUmc leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Recruiting PHASE2/PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- Angiodynamics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .